Eidos Therapeutics, Inc.: 25-NSE filed Jan 26, 2021

Form type

25-NSE

Filing date

Jan 26, 2021

Accession number

0001354457-21-000105

Filer

Eidos Therapeutics, Inc. (CIK 1731831)